|
Market Closed -
Nasdaq
16:30:00 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 0.6574 USD | -3.32% |
|
-7.66% | -42.33% |
| 10-26 | Top Premarket Gainers | MT |
| 10-12 | Iridex Says Glaucoma Therapy Lowers Eye Pressure, Reduces Medication Use | MT |
Business description: IRIDEX Corporation

Number of employees: 93
Sales by Activity: IRIDEX Corporation
| Fiscal Period: January | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
Ophthalmology | 53.9M | 56.97M | 51.87M | 48.67M | 52.68M |
Geographical breakdown of sales: IRIDEX Corporation
| Fiscal Period: January | 2021 (USD) | 2022 (USD) | 2023 (USD) | 2024 (USD) | 2025 (USD) |
|---|---|---|---|---|---|
United States | 25.56M | 29.18M | 26.05M | 22.69M | 23.21M |
Europe, Middle East and Africa | - | 13.8M | 13.52M | 11.82M | 14.39M |
Asia/Pacific Rim | 12.23M | 10.93M | 10.23M | 11.95M | 12.95M |
Americas Excluding the U.S. | 2.54M | 3.06M | 2.06M | 2.2M | 2.12M |
Europe | 13.57M | - | - | - | - |
Executive Committee: IRIDEX Corporation
| Manager | Title | Age | Since |
|---|---|---|---|
Patrick Mercer
CEO | Chief Executive Officer | 54 | 2024-09-30 |
Romeo Dizon
DFI | Director of Finance/CFO | 68 | 2018-12-17 |
Philip Taylor
IRC | Investor Relations Contact | - | - |
Bassem BouHabib
SAM | Sales & Marketing | 50 | 2019-07-31 |
Mary Dy
HRO | Human Resources Officer | - | - |
Composition of the Board of Directors: IRIDEX Corporation
| Director | Title | Age | Since |
|---|---|---|---|
Scott Shuda
CHM | Chairman | 60 | 2020-06-23 |
Patrick Mercer
BRD | Director/Board Member | 54 | 2018-08-31 |
Beverly A. Huss
BRD | Director/Board Member | 66 | 2022-03-16 |
William Moore
CHM | Chairman | 77 | 2010-08-31 |
Yu-Hao Chen
BRD | Director/Board Member | 45 | 2025-03-18 |
Company details: IRIDEX Corporation

Other Advanced Medical Equipment & Technology
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.32% | -7.66% | -37.69% | -70.91% | 11.55M | ||
| +2.63% | -0.32% | +21.37% | +51.28% | 257B | ||
| +1.73% | -0.85% | +9.67% | +16.14% | 162B | ||
| -3.36% | +4.81% | -19.14% | +62.47% | 157B | ||
| -4.23% | +1.83% | -57.26% | -18.06% | 61.96B | ||
| +1.31% | +11.01% | +22.48% | +53.52% | 58.73B | ||
| -0.76% | +4.13% | +3.16% | -6.90% | 55.42B | ||
| +1.73% | -0.06% | +19.09% | +58.10% | 49.27B | ||
| -2.05% | -2.95% | +3.01% | +56.47% | 49.18B | ||
| +1.00% | -1.11% | +23.11% | +75.55% | 44.96B | ||
| Average | -0.53% | +0.46% | -1.22% | +27.77% | 89.59B | |
| Weighted average by Cap. | +0.26% | +1.20% | +4.62% | +40.52% |
Sector

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IRIX Stock
- Company IRIDEX Corporation
Select your edition
All financial news and data tailored to specific country editions

















